- Home
- ACIU vs POWW Comparison
ACIU vs POWW Comparison
Compare ACIU & POWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- POWW
- Stock Information
- Founded
- ACIU 2003
- POWW 1990
- Country
- ACIU Switzerland
- POWW United States
- Employees
- ACIU N/A
- POWW N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- POWW Ordnance And Accessories
- Sector
- ACIU Health Care
- POWW Industrials
- Exchange
- ACIU Nasdaq
- POWW Nasdaq
- Market Cap
- ACIU 189.1M
- POWW 155.4M
- IPO Year
- ACIU 2016
- POWW N/A
- Fundamental
- Price
- ACIU $2.07
- POWW $1.24
- Analyst Decision
- ACIU Strong Buy
- POWW Buy
- Analyst Count
- ACIU 1
- POWW 2
- Target Price
- ACIU $12.00
- POWW $1.75
- AVG Volume (30 Days)
- ACIU 125.1K
- POWW 593.1K
- Earning Date
- ACIU 08-05-2025
- POWW 08-24-2025
- Dividend Yield
- ACIU N/A
- POWW N/A
- EPS Growth
- ACIU N/A
- POWW N/A
- EPS
- ACIU N/A
- POWW N/A
- Revenue
- ACIU $32,014,254.00
- POWW $44,429,095.00
- Revenue This Year
- ACIU N/A
- POWW $123.84
- Revenue Next Year
- ACIU $533.21
- POWW N/A
- P/E Ratio
- ACIU N/A
- POWW N/A
- Revenue Growth
- ACIU 91.20
- POWW N/A
- 52 Week Low
- ACIU $1.43
- POWW $0.95
- 52 Week High
- ACIU $4.26
- POWW $2.14
- Technical
- Relative Strength Index (RSI)
- ACIU 55.57
- POWW 43.46
- Support Level
- ACIU $2.00
- POWW $1.08
- Resistance Level
- ACIU $2.15
- POWW $1.26
- Average True Range (ATR)
- ACIU 0.13
- POWW 0.06
- MACD
- ACIU -0.01
- POWW 0.01
- Stochastic Oscillator
- ACIU 80.92
- POWW 59.26
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About POWW AMMO Inc.
Outdoor Holding Co Formerly AMMO Inc is the owner of GunBroker.com, the online marketplace serving the firearms and shooting sports industries, and a vertically integrated producer of high-performance ammunition and components. It engages in the design, manufacture, and market of ammunition products in the Shooting sports industry in the United States. The firm's product segment comprises Ammunition and Marketplace. The Ammunition segment engages in the design, production, and marketing of ammunition and ammunition component products and the marketplace segment consists of the GunBroker.com marketplace. The company generates the majority of its revenue from the Ammunition segment.